This article is more than 5 years old. Information may no longer be current.

Ocular Therapeutix reports $18.7 million loss in second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ocular Therapeutix reported a net loss of $18.7 million, or $0.64 per share, in the second quarter of 2017 compared with a net loss of $11.4 million, or $0.46 per share, in 2016’s second quarter.

Product sales of ReSure sealant generated $0.4 million in revenue, according to a press release.

Total costs and operating expenses were $18.8 million for the quarter compared with $11.5 million in 2016, while research and development expenses were up from $7 million to $8.1 million.

The company had cash, cash equivalents and marketable securities of $66 million as of June 30.